首页> 外国专利> 2-2-(HYDROXYACETYL)AMINO-4-PYRIDINYLMETHYLTHIO-N-4-(TRIFLUOROMETHOXY)PHENYL-3-PYRIDINECARBOXAMIDE BENZENESULFONATE, CRYSTAL OF SAME, CRYSTAL POLYMORPH THEREOF, AND METHODS FOR PRODUCTION THEREOF

2-2-(HYDROXYACETYL)AMINO-4-PYRIDINYLMETHYLTHIO-N-4-(TRIFLUOROMETHOXY)PHENYL-3-PYRIDINECARBOXAMIDE BENZENESULFONATE, CRYSTAL OF SAME, CRYSTAL POLYMORPH THEREOF, AND METHODS FOR PRODUCTION THEREOF

机译:2-[[[[2-[(羟基乙酰基)酰胺基] -4-吡啶基]甲基]硫] -N- [4-(三氟甲苯氧基)苯基] -3-吡啶甲酸羧甲磺酸酯,相同的晶体,晶体多晶及其方法生产

摘要

In the course of developing 2-[[[2-[(hydroxyacetyl) amino]-4-pyridinyl] methyl] thio]-N-[4-(trifluoromethoxy) phenyl]-3-pyridinecarboxamide (compound A), there are the multiple problems: 1) compound A or its salt is difficult to be recrystallized, the storage stability largely differs depending on the kind of the salt, and it is very difficult to obtain a salt of compound A having excellent storage stability; 2) in a crystallization process of compound A, it is very difficult to control a crystal polymorph, and 3) compound A (free body) causes mineral deposition in the stomach when it is orally administered repeatedly. For solving these problems, we made examination focusing on the kind of the salt and, as a result, found that 1) benzenesulfonate of compound A does not decompose by light, humidity and other factors in a 1-week preliminary stability test (severe test), and has no problem in its storage stability, 2) a method of selectively producing two kinds of crystal forms of benzenesulfonate of compound A, and that 3) no mineral deposition in the stomach is observed even after a 4-week repeated oral administration.
机译:在开发2-[[[[[[[[[[[[[[[[[[[[[[[[[[[[[羟基将乙酰氨基)氨基] -4-吡啶)甲基]硫代] -N- [4-(三氟甲氧基)苯基] -3-吡啶甲酰胺(化合物A)的过程中多重问题:1)化合物A或其盐难以重结晶,其储存稳定性根据盐的种类而有很大差异,并且很难获得具有优异储存稳定性的化合物A的盐; 2)在化合物A的结晶过程中,很难控制晶体多晶型物,并且3)反复口服时,化合物A(游离体)在胃中引起矿物质沉积。为了解决这些问题,我们针对盐的种类进行了检查,结果发现:1)在1周的初步稳定性测试中,化合物A的苯磺酸盐不会因光,湿度和其他因素而分解(严重测试)。 ),并且在储存稳定性方面没有问题; 2)选择性生产两种化合物A的苯磺酸盐晶型的方法,以及3)即使在反复口服4周后,在胃中也未观察到矿物质沉积。

著录项

  • 公开/公告号US2017081286A1

    专利类型

  • 公开/公告日2017-03-23

    原文格式PDF

  • 申请/专利权人 SANTEN PHARMACEUTICAL CO. LTD.;

    申请/专利号US201615368028

  • 发明设计人 MASASHI NIWA;HIROSHI DEGUCHI;

    申请日2016-12-02

  • 分类号C07D213/82;

  • 国家 US

  • 入库时间 2022-08-21 13:49:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号